Business Standard

Kabra Drugs standalone net profit declines 66.67% in the June 2017 quarter

Image

Capital Market

Sales decline 52.27% to Rs 0.84 crore

Net profit of Kabra Drugs declined 66.67% to Rs 0.01 crore in the quarter ended June 2017 as against Rs 0.03 crore during the previous quarter ended June 2016. Sales declined 52.27% to Rs 0.84 crore in the quarter ended June 2017 as against Rs 1.76 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales0.841.76 -52 OPM %8.336.25 -PBDT0.070.09 -22 PBT0.010.03 -67 NP0.010.03 -67

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 15 2017 | 4:38 PM IST

Explore News